University of Chicago researchers, including Patrick Wilson, PhD, professor of medicine, UChicago Biological Sciences Division, have filed a patent for a panel of antibodies that neutralize a range of influenza strains. Keep reading
In May, the Polsky Center ran a special four-week program for Argonne’s Chain Reaction Innovations (CRI) accelerator. Six teams participated in this virtual I-Corps program, which included researchers from other institutions: Axion Technologies has developed a novel mechanism for leveraging… Keep reading
The Polsky Center ran its National Science Foundation (NSF)-supported I-Corps program virtually during the Spring quarter and accepted the largest number of teams of any cohort managed to-date. Polsky supported 13 teams focused on STEM projects in the seven-week program:… Keep reading
Every year, at least 2.8 million people in the US get an antibiotic-resistant infection – and more than 35,000 people die, according to the CDC. In this week’s featured patent, researchers describe methods and compositions for treating or… Keep reading
Researchers, including Aaron Esser-Kahn, an associate professor at UChicago’s Pritzker School of Molecular Engineering, have filed a patent application for a novel additive that limits undesirable… Keep reading
Researchers have developed a highly-optimized recombinant antibody phage-display library to accelerate drug development. Keep reading
Preeti Chalsani (center) at the Chicago Quantum Summit, which is hosted by the Chicago Quantum Exchange. (Photo by Anne Ryan) The Polsky Center for Entrepreneurship and Innovation and the Chicago Quantum Exchange (CQE) have announced a joint effort to enhance… Keep reading
A biologic drug delivery platform targets the treatment of inflammatory diseases by honing in on collagen exposed by inflammation. “Enhancing the therapeutic efficacy of drugs for inflammatory diseases is of high demand,” noted researchers, including… Keep reading
